Blood Cells Molecules and Diseases

Elsevier BV

Journal websitePeer review: Peer review
Evaluation status available after sign-in

About the journal

Blood Cells Molecules and Diseases is a journal published by Elsevier BV in United States. It is listed in MEDLINE and PUBMED according to the sources read. Declared publication charge: 3,740 USD. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.

Basic facts

Publisher
Elsevier BV
ISSN
1079-9796 · 1096-0961
Country
United States
Access
Not open access / not declared
Declared publication charge
3,740 USD
Declared peer-review model
peer_review

Index listings

  • MEDLINE · 1995-01-01
  • PUBMED · 2010-01-15
Indexing
MEDLINE · PUBMED
APC
3,740 USD
Declared review time (DOAJ)
—
Actual review time (measured)
55 days received→accepted — computed from PubMed (n=76)
Activity (OpenAlex)
Active — latest works 2026
PublishLens list status
Shown after sign-in
Counts for promotion at your university?
Choose your university and rank below ↓

Methodology signals (dated facts from their sources)

Details of the evaluation under the published methodology are shown to signed-in users (free).

Create a free account to view the evaluation

Journal profile

Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.

Works in OpenAlex

3044

Last recorded publication year

2026

Reported by OpenAlex in 1 of 3 sources (CC0 flags, not verified indexing)DOAJSciELOOpenAlex Core

h-index

113

i10-index

1694

From OpenAlex open data (CC0).

Editorial & policy4
Observed digital preservation (Keepers registry)— snapshot 2026-10-05
CLOCKSSPortico
Norwegian register (HK-dir)— 2026
Level 1 — approved scholarly channel
Open references deposited at Crossref
86%
ORCID iDs in current deposits
12%
Deposits licence metadata at Crossref
✓
Identity & continuity3
Alternate titles
BCMDBlood cells, molecules, and diseases
Source type
journal
NLM unique ID (PubMed)
9509932
Classification(no data)

No data available to the platform for this group

No platform data for: Classification — absence is not a judgment about the journal.

Subject areas

  • Hemoglobinopathies and Related Disorders
  • Hemoglobinopathies and Related Disorders
  • Hemoglobinopathies and Related Disorders
  • Iron Metabolism and Disorders
  • Iron Metabolism and Disorders
  • Iron Metabolism and Disorders
  • Erythrocyte Function and Pathophysiology
  • Erythrocyte Function and Pathophysiology
Show all subjects (75)
  • Hematopoietic Stem Cell Transplantation
  • Hemoglobin structure and function
  • Glycogen Storage Diseases and Myoclonus
  • Acute Myeloid Leukemia Research
  • Lysosomal Storage Disorders Research
  • Platelet Disorders and Treatments
  • Erythrocyte Function and Pathophysiology
  • Lysosomal Storage Disorders Research
  • Lysosomal Storage Disorders Research
  • Blood groups and transfusion
  • Acute Myeloid Leukemia Research
  • Acute Myeloid Leukemia Research
  • Blood groups and transfusion
  • Blood groups and transfusion
  • Metabolism and Genetic Disorders
  • Neurological diseases and metabolism
  • Trace Elements in Health
  • Trace Elements in Health
  • Blood Coagulation and Thrombosis Mechanisms
  • Genomics and Chromatin Dynamics
  • Diverse Scientific and Economic Studies
  • Human auditory perception and evaluation
  • Diverse Scientific and Economic Studies
  • Human auditory perception and evaluation
  • Educational Robotics and Engineering
  • Educational Robotics and Engineering
  • Neonatal Health and Biochemistry
  • Neonatal Health and Biochemistry
  • Blood properties and coagulation
  • Hematopoietic Stem Cell Transplantation
  • Platelet Disorders and Treatments
  • Hematopoietic Stem Cell Transplantation
  • Platelet Disorders and Treatments
  • Virus-based gene therapy research
  • Neonatal Health and Biochemistry
  • Blood Coagulation and Thrombosis Mechanisms
  • Blood Coagulation and Thrombosis Mechanisms
  • Myeloproliferative Neoplasms: Diagnosis and Treatment
  • Myeloproliferative Neoplasms: Diagnosis and Treatment
  • Blood properties and coagulation
  • Blood properties and coagulation
  • Cellular transport and secretion
  • Cellular transport and secretion
  • Blood disorders and treatments
  • Retinoids in leukemia and cellular processes
  • Immune Cell Function and Interaction
  • Immune Cell Function and Interaction
  • Genetic Associations and Epidemiology
  • Mesenchymal stem cell research
  • Erythropoietin and Anemia Treatment
  • Epigenetics and DNA Methylation
  • Epigenetics and DNA Methylation
  • Acute Lymphoblastic Leukemia research
  • Immunodeficiency and Autoimmune Disorders
  • Hemophilia Treatment and Research
  • Chronic Lymphocytic Leukemia Research
  • Chronic Lymphocytic Leukemia Research
  • Chronic Myeloid Leukemia Treatments
  • Acute Lymphoblastic Leukemia research
  • Acute Lymphoblastic Leukemia research
  • Chronic Myeloid Leukemia Treatments
  • Trypanosoma species research and implications
  • Trypanosoma species research and implications
  • Virus-based gene therapy research
  • Virus-based gene therapy research
  • CRISPR and Genetic Engineering
  • CRISPR and Genetic Engineering

Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.

Loading community confirmations…
How do we evaluate?Publisher of this journal? Appeal a derived assessment or request a factual correction

The journal's record in other sources:Web of Science MJLDOAJ

Everything shown here is produced automatically from named sources (DOAJ, OpenAlex, Crossref, PubMed, the Norwegian register) as of its capture date, with no human editing. Facts appear as recorded at the source; derived scores (PCI, PTD, PublishLens score) follow a published methodology. Not a judgement on the journal, not an official accreditation, not advice.

Wrong items are corrected automatically by re-reading the source (24 h for daily sources, 7 days for weekly ones) with a dated change log, and each item links to its source record. PublishLens-derived assessments are contested through the appeals mechanism (15 working days). Appeals · Indicator guide

Norwegian register data: Kanalregisteret (HK-dir, Norway) — CC BY 4.0 / NLOD — adapted: level extracted per year · OASPA member list — CC BY

Last automated source read: